Characterization of an Endothelial 5-hydroxytryptamine (5-HT) Receptor Mediating Relaxation of the Porcine Coronary Artery
Overview
Authors
Affiliations
The pharmacological properties of the endothelial 5-hydroxytryptamine (5-HT) receptors involved in relaxation of vascular smooth muscle were determined in rings of pig coronary artery contracted with 10 nmol/l of the thromboxane A2 receptor agonist 9,11-dideoxy-11 alpha,9 alpha-epoxy-methano-prostaglandin F2 alpha (U 46619). (1) In the presence of 10 mumol/l ketanserin, relaxation was obtained with: 5-HT (apparent pD2 value 7.00), 5-carboxamidotryptamine (5-CONH2-T; 6.42), 5-aminotryptamine (5-NH2-T; 5.96), 5-methoxytryptamine (5-OCH3-T; 5.92), tryptamine, 7-trifluoromethyl-4(4-methyl-1-piperazinyl)-pyrrolo(1,2-a)quinoxaline maleate (CGS 12066 A) and 5-methoxy-3(1,2,3,6-tetrahydro-4-pyridinyl)-1H-indole succinate (RU 24969). The maximum relaxation obtainable with the agonists was about 40-60% of the U 46619-induced contraction and the concentration-response curves for 5-HT, 5-NH2-T and 5-OCH3-T were bell-shaped. The endothelium-dependence of this effect (i.e. the failure to relax the artery in endothelium-denuded preparations) was demonstrated for 5-HT, 5-CONH2-T, RU 24969, CGS 12066A and tryptamine. (2) 8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), 4-hydroxytryptamine, quipazine and yohimbine were ineffective in decreasing the tension of arteries with or without endothelium. Ipsapirone elicited full relaxation of U 46619-induced contraction, but this effect was not endothelium-dependent.(ABSTRACT TRUNCATED AT 250 WORDS)
Elhusseiny A, Hamel E Br J Pharmacol. 2001; 132(1):55-62.
PMID: 11156561 PMC: 1572524. DOI: 10.1038/sj.bjp.0703763.
Glusa E, Roos A Br J Pharmacol. 1996; 119(2):330-4.
PMID: 8886417 PMC: 1915880. DOI: 10.1111/j.1476-5381.1996.tb15990.x.
Schoeffter P, Ullmer C, Gutierrez M, Lubbert H Naunyn Schmiedebergs Arch Pharmacol. 1995; 352(5):580-2.
PMID: 8751089 DOI: 10.1007/BF00169394.
Endothelium-dependent relaxation of porcine pulmonary arteries via 5-HT1C-like receptors.
Glusa E, Richter M Naunyn Schmiedebergs Arch Pharmacol. 1993; 347(5):471-7.
PMID: 8391650 DOI: 10.1007/BF00166737.
Whiting M, Cambridge D Br J Pharmacol. 1995; 114(5):969-74.
PMID: 7780652 PMC: 1510329. DOI: 10.1111/j.1476-5381.1995.tb13299.x.